Heallo Overview

  • Status
  • Private

  • Latest Deal Type
  • Crowdfunding

  • Latest Deal Amount
  • $998K

Heallo General Information


Developer of a proprietary technology intended to reduce the glycemic index in food products. The company's technology of hydrolysis is used for the extraction of bioavailable arabinoxylans to use in various food items to minimize the impact on eating habits post-prandial glycemic increase to counter intake problems, thereby providing businesses with nutritional food technology solutions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Consulting Services (B2B)
Primary Office
  • 13 Corso Europa
  • Lombardy
  • 20122 Milan
  • Italy

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Heallo Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Equity Crowdfunding $998K 00000 Completed Startup
To view Heallo’s complete valuation and funding history, request access »

Heallo Patents

Heallo Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3135911-A1 Hydrolysis of brewer's spent grain Pending 11-Apr-2019 000000000
EP-3953487-A1 Hydrolysis of brewer's spent grain Pending 11-Apr-2019 000000000
JP-2022528204-A Hydrolysis of beer lees Pending 11-Apr-2019 000000000
US-20220195475-A1 Hydrolysis of brewer's spent grain Pending 11-Apr-2019 C12P19/00

Heallo Executive Team (2)

Name Title Board Seat Contact Info
Francesca Varvello Co-Founder and Chief Executive Officer
Franco Varvello Co-Founder
To view Heallo’s complete executive team members history, request access »